Urology Market Analysis, Size, Trends | China | 2020-2026 | MedSuite

Urology Market Analysis, Size, Trends | China | 2020-2026 | MedSuite

0

  • Year: 2020
  • Scope: 2016-2026
  • Region: China
  • Published Date: 11/26/2019
  • Pages: 369
  • Type: MedSuite

By 2020, the urological device market size in China was valued at nearly $540 million, with over 2.4 million urological procedures performed every year. The market value is expected to increase at a compound annual growth rate (CAGR) of 1.7% to reach $605 million in 2026.

Throughout this medical market research, we analyzed 49 urology companies across China and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

While this MedSuite report contains all of the Chinese Urological Device market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Urology Procedure Volumes
  • Market Forecasts Until 2026, and Historical Data to 2016
  • Competitive Analysis with Market Shares for Each Segment
  • Market Drivers & Limiters for Each Urological Device market
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Market Value and Industry Trends

The stable growth across the market is driven by an increasing number of procedures performed, fueled by the growing geriatric population and the incidence rates of associated diseases, including urinary incontinence, pelvic organ prolapse, urolithiasis, nephrolithiasis and prostatic diseases. Moreover, complications of BPH treatment may result in urinary incontinence, providing a correlation between markets for the related treatment devices.

 

The urinary incontinence management device market, followed by the stone management device market and BPH treatment were the largest segments of the total market, accounting for the vast majority of the total market value in 2019. The growth of the urinary incontinence management device market is primarily driven by the catheter segment, which will account for the majority of the market growth. The growth in the stone management and BPH treatment device segments is driven by the stable demand for related procedures, the growing prevalence of prostatic and kidney diseases, and the premium prices for lasers and lithotripters.

Competitive Analysis

China Urology Market LeadersBy 2020, the leading competitor in the Chinese urology market was Boston Scientific. The company led the urinary incontinence management device market, pelvic organ prolapse repair market, stone management, and erectile dysfunction treatment market. The company’s leading position is attributed to its established products, including men’s health and prostate health businesses.

BARD was the second-leading competitor in the urological device market in China. This was attributed to the company’s notable presence in the urinary incontinence market, as well as its share of the pelvic organ prolapse repair and stone management device markets.

Accu-Tech held the third-leading share of the Chinese market by 2020, primarily attributed to its presence in the stone management device market and BPH treatment device market, the second and the third-largest segments of the total market.

Segments Covered

Click on each title to view detailed market segmentation.

  • Procedure Numbers for Urological Devices – MedPro – Discusses urological procedures performed in China. The analysis includes interventional benign prostatic hyperplasia (BPH) treatment, pelvic organ prolapse repair, stone management,  urinary incontinence, and erectile dysfunction management procedures further broken down by device type.
  • Urinary Incontinence Market  – MedCore – In-depth analysis of the Urinary Incontinence Device Market. The chapter includes Urinary Catheter, Urethral Bulking Agent, and Incontinence Management device markets.
  • Pelvic Organ Prolapse Repair Market – MedCore – The market is comprised of the segments for Transvaginal and Sacrocolpopexy Meshes.
  • Stone Management Market –  MedCore – This market is categorized by Device Type into ESWL Equipment, ISWL Equipment, Holmium Lasers, Stone Fragment Retrieval Device, Ureteral Stent, and Ureteral Guidewire market segments.
  • BPH Treatment Market – MedCore – This market is segmented by Device Type, including Transurethral Resection of Prostate (TURP), Laser BPH, UroLift, and Rezūm devices.
  • Erectile Dysfunction Market – MedCore – In-depth analysis of the Erectile Dysfunction device market. The chapter includes market segments, such as the Inflatable, Malleable, and Vacuum Erectile Dysfunction device markets.

Detailed Market Segmentation

China Urological Device Market Segmentation - p1China Urology Market Segmentation - p2

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

TABLE OF CONTENTS For the CHINA UROLOGY MARKET Report Suite

TABLE OF CONTENTS I
LIST OF FIGURES X
LIST OF CHARTS XIX
EXECUTIVE SUMMARY 1
CHINA UROLOGICAL DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 5
MARKET DEVELOPMENTS 6
PROCEDURE NUMBERS 7
MARKETS INCLUDED 8
VERSION HISTORY 9
RESEARCH METHODOLOGY 10
Step 1: Project Initiation & Team Selection 10
Step 2: Prepare Data Systems and Perform Secondary Research 13
Step 3: Preparation for Interviews & Questionnaire Design 15
Step 4: Performing Primary Research 16
Step 5: Research Analysis: Establishing Baseline Estimates 18
Step 6: Market Forecast and Analysis 19
Step 7: Identify Strategic Opportunities 21
Step 8: Final Review and Market Release 22
Step 9: Customer Feedback and Market Monitoring 23

DISEASE OVERVIEW

2.1 BASIC ANATOMY 24
2.1.1 Urinary System 24
2.1.1.1 Male Urinary System 25
2.1.1.2 Female Urinary System 26
2.2 DISEASE TREATMENT AND DIAGNOSTICS 27
2.2.1 Benign Prostatic Hyperplasia 27
2.2.2 Urinary Incontinence 29
2.2.3 Urinary Tract Infections 31
2.2.4 Kidney Stones 32
2.2.5 Bladder Prolapse 34
2.2.6 Overactive Bladder 35
2.2.7 Prostatitis 36
2.2.8 Erectile Dysfunction 38
2.2.9 Cancer 40
2.2.9.1 Prostate Cancer 40
2.2.9.2 Bladder Cancer 41
2.2.10 Indications for Pelvic Organ Prolapse Repair 42

PRODUCT ASSESSMENT

3.1 INTRODUCTION 44
3.2 PRODUCT PORTFOLIOS 44
3.2.1 Urinary Incontinence 44
3.2.1.1 Urinary Catheters 44
3.2.1.1.1 Intermittent Catheters 44
3.2.1.1.2 Foley Catheters 45
3.2.1.1.3 Male External Catheters 46
3.2.1.2 Urethral Bulking Agents 47
3.2.1.3 Incontinence Management Devices 48
3.2.1.3.1 Female Incontinence Slings 48
3.2.1.3.2 Male Implantable Devices 49
3.2.1.4 Urine Bags 51
3.2.1.4.1 Leg Bags 51
3.2.1.4.2 Night Bags 51
3.2.2 Pelvic Organ Prolapse Repair 56
3.2.2.1 Autologous Tissue as an Alternative to Vaginal Mesh 57
3.2.2.2 Product Matrix for Pelvic Organ Prolapse Repair 58
3.2.3 Stone Management 59
3.2.3.1 ESWL Equipment 59
3.2.3.2 ISWL Equipment 60
3.2.3.3 Holmium Lasers 60
3.2.3.4 Stone Fragment Retrieval Devices 61
3.2.3.5 Ureteral Stents 61
3.2.4 BPH Treatment 65
3.2.4.1 TURP 65
3.2.4.2 TUMT 66
3.2.4.3 TUNA 66
3.2.4.4 Prostatic Stents 67
3.2.4.5 Laser BPH 68
3.2.4.5.1 Photoselective Vaporization of the Prostate (PVP) 69
3.2.4.5.2 Laser Vaporization of the Prostate 70
3.2.4.5.3 Laser Ablation of the Prostate 71
3.2.4.5.4 Laser Resection of the Prostate 71
3.2.4.5.5 Laser Enucleation of the Prostate 72
3.2.5 Erectile Dysfunction 74
3.2.5.1 Penile Implants 74
3.2.5.1.1 Inflatable 74
3.2.5.1.2 Malleable 75
3.2.5.2 Vacuum 75
3.3 REGULATORY ISSUES AND RECALLS 77
3.3.1 Boston Scientific 77
3.3.1.1 Stone Management 77
3.3.1.2 Nephrostomy 79
3.3.2 C. R. Bard (Becton Dickinson) 80
3.3.2.1 Urinary Incontinence 80
3.3.2.2 Stone Management 85
3.3.2.3 Urological Endoscopes 85
3.3.2.4 Prostate Cancer Treatment 85
3.3.2.5 Nephrostomy 86
3.3.3 Coloplast 88
3.3.3.1 Urinary Catheter 88
3.3.3.2 Erectile Dysfunction 88
3.3.4 Cook Medical 89
3.3.4.1 Stone Management 89
3.3.4.2 Nephrostomy 90
3.3.5 Elekta 92
3.3.5.1 Prostate Cancer Treatment 92
3.3.6 Karl Storz 93
3.3.6.1 Urological Endoscopes 93
3.3.7 Olympus 94
3.3.7.1 Urological Endoscopes 94
3.4 CLINICAL TRIALS 96
3.4.1 Boston Scientific 96
3.4.1.1 Urinary Incontinence 96
3.4.1.2 BPH Treatment 97
3.4.1.3 Urological endoscopes 98
3.4.1.4 Nephrostomy 99
3.4.1.5 Erectile Dysfunction 100
3.4.2 C. R. Bard (Becton Dickinson) 101
3.4.2.1 Urinary Incontinence 101
3.4.2.2 Prostate Cancer Treatment 103
3.4.3 Coloplast 104
3.4.3.1 Urinary Incontinence 104
3.4.4 Cook Medical 107
3.4.4.1 Nephrostomy 107
3.4.5 Elekta 109
3.4.5.1 Prostate Cancer Treatment 109
3.4.6 Ethicon 111
3.4.6.1 Urinary Incontinence 111
3.4.7 Karl Storz 113
3.4.7.1 Stone Management 113
3.4.7.2 Urological Endoscopes 115
3.4.8 Laborie 118
3.4.8.1 Urodynamics 118
3.4.9 Medline 120
3.4.9.1 Urinary Incontinence 120
3.4.10 Olympus 121
3.4.10.1 Stone Management 121
3.4.10.2 BPH Treatment 122
3.4.10.3 Urological Endoscopes 123

CHINA UROLOGICAL DEVICE MARKET OVERVIEW

4.1 INTRODUCTION 125
4.2 CURRENCY EXCHANGE RATE 127
4.3 MARKET OVERVIEW 128
4.4 TREND ANALYSIS BY SEGMENT 134
4.5 DRIVERS AND LIMITERS 137
4.5.1 Market Drivers 137
4.5.2 Market Limiters 139
4.6 COMPETITIVE MARKET SHARE ANALYSIS 143
4.7 MERGERS AND ACQUISITIONS 152
4.8 COMPANY PROFILES 154
4.8.1 Boston Scientific 154
4.8.2 C. R. Bard (Becton Dickinson) 156
4.8.3 Coloplast 158
4.8.4 Cook Medical 159
4.8.5 Ethicon 160
4.8.6 Karl Storz 161
4.8.7 Laborie 162
4.8.8 Olympus 163
4.9 SWOT ANALYSIS 165
4.9.1 Boston Scientific 166
4.9.2 C. R. Bard (Becton Dickinson) 168
4.9.3 Coloplast 170
4.9.4 Cook Medical 171
4.9.5 Ethicon 173
4.9.6 Karl Storz 174
4.9.7 Laborie 175
4.9.8 Olympus 176

PROCEDURE NUMBERS

5.1 PROCEDURE OVERVIEW 178
5.2 URINARY INCONTINENCE PROCEDURES 183
5.2.1 Male Incontinence Management Procedures 185
5.2.2 Female Incontinence Management Procedures 187
5.3 PELVIC ORGAN PROLAPSE REPAIR 190
5.4 STONE MANAGEMENT PROCEDURES 192
5.4.1 ESWL Procedures 194
5.4.2 Transurethral Procedures 196
5.4.3 Ureteral Stent Placement Procedures 198
5.4.4 PCNL Procedures 200
5.5 BPH PROCEDURES 202
5.6 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 204

URINARY INCONTINENCE MANAGEMENT DEVICE MARKET

6.1 INTRODUCTION 206
6.2 MARKET OVERVIEW 207
6.3 MARKET ANALYSIS AND FORECAST 212
6.3.1 Total Urinary Catheter Market 212
6.3.1.1 Intermittent Catheter Market 215
6.3.1.2 Foley Catheter Market 217
6.3.1.3 Male External Catheter Market 219
6.3.2 Total Incontinence Management Device Market 221
6.3.2.1 Total Female Incontinence Sling Market 224
6.3.2.1.1 Transvaginal Tape Female Incontinence Sling Market 229
6.3.2.1.2 Transobturator Female Incontinence Sling Market 231
6.3.2.1.3 Single-Incision Female Incontinence Sling Market 233
6.3.2.2 Total Male Implantable Incontinence Device Market 235
6.3.2.2.1 Male Incontinence Sling Market 240
6.3.2.2.2 Male Artificial Urinary Sphincter Market 242
6.3.3 Urethral Bulking Agent 244
6.4 DRIVERS AND LIMITERS 245
6.4.1 Market Drivers 245
6.4.2 Market Limiters 245
6.5 COMPETITIVE MARKET SHARE ANALYSIS 247

PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET

7.1 INTRODUCTION 252
7.2 MARKET OVERVIEW 254
7.3 MARKET ANALYSIS AND FORECAST 259
7.3.1 Total Pelvic Organ Prolapse Repair Device Market 259
7.3.2 Transvaginal Mesh Market 262
7.3.3 Sacrocolpopexy Mesh Market 265
7.4 DRIVERS AND LIMITERS 267
7.4.1 Market Drivers 267
7.4.2 Market Limiters 267
7.5 COMPETITIVE MARKET SHARE ANALYSIS 269

STONE MANAGEMENT DEVICE MARKET

8.1 INTRODUCTION 272
8.2 MARKET OVERVIEW 274
8.3 MARKET ANALYSIS AND FORECAST 280
8.3.1 ESWL Equipment Market 280
8.3.2 ISWL Equipment Market 283
8.3.3 Total Holmium Laser Market 285
8.3.3.1 Holmium Laser Equipment Market 288
8.3.3.2 Holmium Laser Fiber Market 290
8.3.4 Total Stone Fragment Retrieval Device Market 293
8.3.4.1 Nitinol Stone Fragment Retrieval Device Market 298
8.3.4.2 Stainless Steel Stone Fragment Retrieval Device Market 300
8.3.5 Ureteral Stent Market 302
8.3.6 Ureteral Guidewire Market 305
8.4 DRIVERS AND LIMITERS 307
8.4.1 Market Drivers 307
8.4.2 Market Limiters 308
8.5 COMPETITIVE MARKET SHARE ANALYSIS 310

BPH TREATMENT DEVICE MARKET

9.1 INTRODUCTION 317
9.1.1 Treatments 317
9.1.2 Comparison of TURP and Laser BPH Procedures 319
9.1.3 Emerging Technologies 319
9.2 MARKET OVERVIEW 320
9.3 MARKET ANALYSIS AND FORECAST 325
9.3.1 Total TURP Market 325
9.3.1.1 Monopolar Electrode Market 328
9.3.1.2 Bipolar Electrode Market 330
9.3.2 Total Laser BPH Market 332
9.3.2.1 Laser BPH Equipment Market 335
9.3.2.2 Laser BPH Fiber Market 337
9.3.3 UroLift® 339
9.3.4 Rezūm® 340
9.4 DRIVERS AND LIMITERS 341
9.4.1 Market Limiters 342
9.5 COMPETITIVE MARKET SHARE ANALYSIS 345

ERECTILE DYSFUNCTION DEVICE MARKET

10.1 INTRODUCTION 350
10.1.1 Low Testosterone Pharmaceutical Delivery 351
10.2 MARKET OVERVIEW 352
10.3 MARKET ANALYSIS AND FORECAST 357
10.3.1 Inflatable Erectile Dysfunction Device Market 357
10.3.2 Malleable Erectile Dysfunction Device Market 360
10.3.3 Vacuum Erection Device 362
10.4 DRIVERS AND LIMITERS 363
10.4.1 Market Drivers 363
10.4.2 Market Limiters 363
10.5 COMPETITIVE MARKET SHARE ANALYSIS 365

ABBREVIATIONS

The Urology Market Report Suite | China | 2020-2026 | MedSuite includes analysis on the following companies currently active in this market:

  • Accu-Tech
  • Anhui Easyway Medical Supplies
  • Anjue Medical Equipment
  • Augusta Medical Systems
  • BARD
  • Biolitec
  • Bonro Medical
  • Boston Scientific
  • Changzhou JIUHONG Medical Instrument
  • Coloplast
  • Cook Medical
  • CureStar
  • Dornier MedTech
  • Forlong Medical
  • Full Medical
  • Guangzhou MeCan Medical Limited
  • Guangzhou Potent Medical Equipment Joint-Stock
  • Guangzhou Shihai Medical Equipment
  • Hitec Medical Co.
  • Hospital & Homecare Medical Device
  • Hunan Reborn Medical Science and Technology Development
  • Jiaxing U-Life Medical Device Technology
  • Johnson & Johnson
  • Lumenis
  • Nantong
  • Ningbo Finer Medical Instruments
  • Ningbo Luke Medical Devices
  • NWOverseas
  • Olympus
  • Owen Mumford
  • Pengtian Medical
  • Quindao Goodpro International Co.
  • Richard Wolf
  • Shanghai Lumsail Medical and Beauty Equipment
  • Shenzhen Huikang Medical Apparatus
  • Shone Med-Tech
  • Siemens
  • Sunny Medical Equipment
  • Sure Care Corporation
  • Suzhou Acmed Import & Export
  • Suzhou Kmed International Trade
  • Taizhou Juhao Import & Export
  • Teleflex
  • Wellead
  • Xinoray Medical
  • Yilson Medical Technology
  • Yuancure
  • Zhengzhou Hepo International Trading
  • Zhuji Pengtian Medical Instrument

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link
close-link

close-link